Cranberry
NDC Package 54575-383-50
Package Information
Cranberry has been used for reducing the risk of "bladder infections" (urinary tract infections). Marketed by Allergy Laboratories, Inc., this product is identified by NDC 54575-383 and is authorized under FDA application BLA102192.
Identification & Billing
- RxCUI: 1000013 - whole wheat allergenic extract 50 MG/ML Injectable Solution
- RxCUI: 1000013 - whole wheat allergenic extract 0.05 GM/ML Injectable Solution
- RxCUI: 1000013 - whole wheat extract 50 MG/ML Injectable Solution
- RxCUI: 1006300 - Aspergillus niger var. niger allergenic extract 50 MG/ML Injectable Solution
- RxCUI: 1006300 - Aspergillus niger var. niger allergenic extract 0.05 GM/ML Injectable Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 54575 - Allergy Laboratories, Inc.
- 54575-383 - Cranberry
- 54575-383-50 - 50 mL in 1 VIAL, MULTI-DOSE
- 54575-383 - Cranberry
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (54575-383). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54575-383-50 identifies a specific commercial package of 50 ml in 1 vial, multi-dose of Cranberry, labeled by Allergy Laboratories, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Allergy Laboratories, Inc. on August 29, 1972. The current certification is valid through December 31, 2018.
What are the primary indications for this medication?
Cranberry has been used for reducing the risk of "bladder infections" (urinary tract infections). It has also been used for decreasing the smell of urine in people who are unable to control urination (incontinent). This product should not be used alone to treat bladder infections. It may not work, and the delay could allow the infection to worsen. Some herbal/diet supplement products have been found to contain possibly harmful impurities/additives. Check with your pharmacist for more details about the brand you use. The FDA has not reviewed this product for safety or effectiveness. Consult your doctor or pharmacist for more details.
How is this Allergy Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54575038350. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
